MSL
EXAS

Mackay Shields LLC’s Exact Sciences EXAS Stock Holding History

Mackay Shields LLC’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-8,371
Closed -$1.11M – 1517
2020
Q4 		$1.11M Buy
+8,371
New +$1.01M 0.01% 1056
2020
Q1 		– Sell
-2,690
Closed -$249K – 1430
2019
Q4 		$249K Sell
2,690
-300
-10% -$26.4K ﹤0.01% 1245
2019
Q3 		$271K Sell
2,990
-14,579
-83% -$1.66M ﹤0.01% 1345
2019
Q2 		$2.07M Sell
17,569
-38,709
-69% -$3.9M 0.01% 884
2019
Q1 		$4.88M Sell
56,278
-22,195
-28% -$1.89M 0.04% 506
2018
Q4 		$4.95M Buy
+78,473
New +$5.39M 0.04% 470
2018
Q3 		– Sell
-35,161
Closed -$2.1M – 1174
2018
Q2 		$2.1M Sell
35,161
-2,000
-5% -$108K 0.01% 754
2018
Q1 		$1.5M Buy
+37,161
New +$1.81M 0.01% 874

Other funds holding EXAS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Mackay Shields LLC's EXAS Position: Q1 2021 in Review

Mackay Shields LLC sold out of Exact Sciences (EXAS) in Q1 2021, closing a stake of 8,371 shares — an estimated $1.11M sold.

Mackay Shields LLC first reported a position in EXAS in Q1 2018 and held it in 8 quarters. The position peaked at $4.95M in Q4 2018. 645 funds tracked by Wall St. Rank hold EXAS as of Q1 2021.

  • Mackay Shields LLC reported no remaining Exact Sciences position as of Q1 2021 after selling out during the quarter.
  • Mackay Shields LLC sold 8,371 Exact Sciences shares in Q1 2021, an estimated $1.11M.
  • Mackay Shields LLC first reported a position in Exact Sciences in Q1 2018 and held it in 8 quarters.
  • Mackay Shields LLC's Exact Sciences position peaked at $4.95M in Q4 2018.
  • 645 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2021.

Based on Mackay Shields LLC's 13F filing for Q1 2021, filed 14 May 2021.